Observations on enhanced port wine stain blanching induced by combined pulsed dye laser and rapamycin administration.
作者信息
Nelson J Stuart, Jia Wangcun, Phung Thuy L, Mihm Martin C
机构信息
Department of Surgery, Beckman Laser Institute and Medical Clinic, University of California, Irvine 92617, USA.
出版信息
Lasers Surg Med. 2011 Dec;43(10):939-42. doi: 10.1002/lsm.21141. Epub 2011 Nov 29.
Abstract
摘要
相似文献
1
Observations on enhanced port wine stain blanching induced by combined pulsed dye laser and rapamycin administration.联合应用脉冲染料激光和雷帕霉素诱导鲜红斑痣褪色增强的观察
Lasers Surg Med. 2011 Dec;43(10):939-42. doi: 10.1002/lsm.21141. Epub 2011 Nov 29.
2
Port wine stain treated with a combination of pulsed dye laser and topical rapamycin ointment.采用脉冲染料激光和外用雷帕霉素软膏联合治疗葡萄酒色斑。
Lasers Surg Med. 2016 Feb;48(2):193-6. doi: 10.1002/lsm.22436. Epub 2015 Oct 26.
3
Treatment of port wine stain with Tixel-induced rapamycin delivery following pulsed dye laser application.应用脉冲染料激光后，采用 Tixel 递送雷帕霉素治疗葡萄酒色斑。
Dermatol Ther. 2020 Jan;33(1):e13172. doi: 10.1111/dth.13172. Epub 2019 Dec 4.
4
Port-wine stain laser treatments and novel approaches.葡萄酒色斑激光治疗及新方法。
Facial Plast Surg. 2012 Dec;28(6):611-20. doi: 10.1055/s-0032-1329936. Epub 2012 Nov 27.
5
Treatment of port wine stains using Pulsed Dye Laser, Erbium YAG Laser, and topical rapamycin (sirolimus)-A randomized controlled trial.使用脉冲染料激光、铒钇铝石榴石激光和局部雷帕霉素（西罗莫司）治疗葡萄酒色斑——一项随机对照试验。
Lasers Surg Med. 2017 Jan;49(1):104-109. doi: 10.1002/lsm.22548. Epub 2016 Jun 20.
6
Retrospective study of photodynamic therapy for pulsed dye laser-resistant port-wine stains.脉冲染料激光治疗抵抗性葡萄酒色斑的光动力疗法回顾性研究。
J Dermatol. 2020 Apr;47(4):348-355. doi: 10.1111/1346-8138.15238. Epub 2020 Feb 3.
7
Outcome with topical sirolimus for port wine stain malformations after unsatisfactory results with pulse dye laser treatment alone.单独使用脉冲染料激光治疗效果不理想后，外用西罗莫司治疗葡萄酒色斑畸形的结果。
Ann Saudi Med. 2018 Sep-Oct;38(5):376-380. doi: 10.5144/0256-4947.2018.376.
8
Prospective pilot study on combined use of pulsed dye laser and 1% topical rapamycin for treatment of nonfacial cutaneous capillary malformation.脉冲染料激光与1%外用雷帕霉素联合治疗非面部皮肤毛细血管畸形的前瞻性初步研究。
J Dermatolog Treat. 2017 Nov;28(7):672-677. doi: 10.1080/09546634.2017.1306018. Epub 2017 Mar 30.
9
The Development of Hypertrophy in Port-Wine Stains, a Common Phenomenon that Affects Treatment Recommendations.葡萄酒色斑中肥大的发展，这是一种影响治疗建议的常见现象。
Dermatol Surg. 2015 Nov;41(11):1246-8. doi: 10.1097/DSS.0000000000000524.
10
Topical Adjuncts to Pulsed Dye Laser for Treatment of Port Wine Stains: Review of the Literature.用于治疗葡萄酒色斑的脉冲染料激光的局部辅助治疗：文献综述
Dermatol Surg. 2018 Jun;44(6):796-802. doi: 10.1097/DSS.0000000000001507.
引用本文的文献
1
Letter to the Editor.致编辑的信。
Lasers Surg Med. 2024 Oct;56(8):689-690. doi: 10.1002/lsm.23832. Epub 2024 Aug 22.
2
Capillary malformations.毛细血管畸形
J Clin Invest. 2024 Apr 15;134(8):e172842. doi: 10.1172/JCI172842.
3
Evaluating the clinical efficacy of pulsed dye laser with sirolimus for treatment of capillary malformations: A systematic review.评估脉冲染料激光联合西罗莫司治疗毛细血管畸形的临床疗效：一项系统评价。
Skin Health Dis. 2024 Jan 7;4(1):e333. doi: 10.1002/ski2.333. eCollection 2024 Feb.
4
Perturbations of Glutathione and Sphingosine Metabolites in Port Wine Birthmark Patient-Derived Induced Pluripotent Stem Cells.葡萄酒色斑患者来源的诱导多能干细胞中谷胱甘肽和鞘氨醇代谢物的扰动
Metabolites. 2023 Aug 31;13(9):983. doi: 10.3390/metabo13090983.
5
Supporting materials: Endothelial cells differentiated from patient dermal fibroblast-derived induced pluripotent stem cells resemble vascular malformations of Port Wine Birthmark.支持材料：从患者皮肤成纤维细胞来源的诱导多能干细胞分化而来的内皮细胞类似于葡萄酒色斑的血管畸形。
bioRxiv. 2023 Aug 24:2023.07.02.547408. doi: 10.1101/2023.07.02.547408.
6
Perturbations of glutathione and sphingosine metabolites in Port Wine Birthmark patient-derived induced pluripotent stem cells.葡萄酒色斑患者来源的诱导多能干细胞中谷胱甘肽和鞘氨醇代谢物的扰动
bioRxiv. 2023 Jul 19:2023.07.18.549581. doi: 10.1101/2023.07.18.549581.
7
Pathogenesis of Port-Wine Stains: Directions for Future Therapies.葡萄酒色斑的发病机制：未来治疗的方向。
Int J Mol Sci. 2022 Oct 12;23(20):12139. doi: 10.3390/ijms232012139.
8
ISSVA Classification of Vascular Anomalies and Molecular Biology.ISSVA 血管异常分类与分子生物学。
Int J Mol Sci. 2022 Feb 21;23(4):2358. doi: 10.3390/ijms23042358.
9
Vascular anomalies of the head and neck: diagnosis and treatment.头颈部血管异常：诊断与治疗。
Pediatr Radiol. 2021 Jun;51(7):1162-1184. doi: 10.1007/s00247-021-04968-2. Epub 2021 Apr 16.
10
Aesthetic Treatment Outcomes of Capillary Hemangioma, Venous Lake, and Venous Malformation of the Lip Using Different Surgical Procedures and Laser Wavelengths (Nd:YAG, Er,Cr:YSGG, CO, and Diode 980 nm).不同手术程序和激光波长（Nd:YAG、Er,Cr:YSGG、CO 和二极管 980nm）治疗唇部毛细血管畸形、静脉湖和静脉畸形的美容治疗结果。
Int J Environ Res Public Health. 2020 Nov 22;17(22):8665. doi: 10.3390/ijerph17228665.
本文引用的文献
1
Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis.外用雷帕霉素：治疗结节性硬化症面部血管纤维瘤的新方法。
Arch Dermatol. 2010 Jul;146(7):715-8. doi: 10.1001/archdermatol.2010.125.
2
Stem cell marker upregulation in normal cutaneous vessels following pulsed-dye laser exposure and its abrogation by concurrent rapamycin administration: implications for treatment of port-wine stain birthmarks.脉冲染料激光照射后正常皮肤血管中干细胞标志物上调及雷帕霉素同时给药对其的消除作用：对葡萄酒色斑胎记治疗的意义
J Cutan Pathol. 2010 Apr;37 Suppl 1(Suppl 1):76-82. doi: 10.1111/j.1600-0560.2010.01520.x.
3
Long-term blood vessel removal with combined laser and topical rapamycin antiangiogenic therapy: implications for effective port wine stain treatment.联合激光与局部雷帕霉素抗血管生成疗法进行长期血管清除：对鲜红斑痣有效治疗的意义
Lasers Surg Med. 2010 Feb;42(2):105-12. doi: 10.1002/lsm.20890.
4
Regression of pulmonary lymphangioleiomyomatosis (PLAM)-associated retroperitoneal angiomyolipoma post-lung transplantation with rapamycin treatment.肺移植术后使用雷帕霉素治疗使肺淋巴管平滑肌瘤病（PLAM）相关的腹膜后血管平滑肌脂肪瘤消退
J Heart Lung Transplant. 2008 Apr;27(4):462-5. doi: 10.1016/j.healun.2008.01.005.
5
Can the wound healing response of human skin be modulated after laser treatment and the effects of exposure extended? Implications on the combined use of the pulsed dye laser and a topical angiogenesis inhibitor for treatment of port wine stain birthmarks.激光治疗后能否调节人体皮肤的伤口愈合反应并延长暴露的效果？这对脉冲染料激光与局部血管生成抑制剂联合用于治疗葡萄酒色斑胎记的意义。
Lasers Surg Med. 2008 Jan;40(1):1-5. doi: 10.1002/lsm.20599.
6
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.西罗莫司用于治疗结节性硬化症或淋巴管平滑肌瘤病中的肾血管平滑肌脂肪瘤。
N Engl J Med. 2008 Jan 10;358(2):140-51. doi: 10.1056/NEJMoa063564.
7
Targeting the mTOR signaling network in cancer.靶向癌症中的mTOR信号网络。
Trends Mol Med. 2007 Oct;13(10):433-42. doi: 10.1016/j.molmed.2007.08.001. Epub 2007 Oct 1.
8
Defining the role of mTOR in cancer.确定mTOR在癌症中的作用。
Cancer Cell. 2007 Jul;12(1):9-22. doi: 10.1016/j.ccr.2007.05.008.
9
Dramatic effect of sirolimus on renal angiomyolipomas in a patient with tuberous sclerosis complex.西罗莫司对结节性硬化症患者肾血管平滑肌脂肪瘤的显著疗效。
Eur J Intern Med. 2007 Jan;18(1):76-7. doi: 10.1016/j.ejim.2006.07.017.
10
Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex.雷帕霉素在与结节性硬化症相关的肾血管平滑肌脂肪瘤中的抗肿瘤活性。
Am J Kidney Dis. 2006 Sep;48(3):e27-9. doi: 10.1053/j.ajkd.2006.05.018.
Zotero 插件